
|Articles|July 13, 2023
Orphan Drug Development - A Pragmatic Approach to Developing a Rare Disease Drug
Author(s)Curia
Trending on Pharmaceutical Technology
1
Peptide Compounding Vote Raises New Questions for Drug Developers
2
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
3
PharmTech Weekly Roundup—July 17, 2026
4
Q&A : Brent Wilhelm on Supply Chains and Historical Demand Data
5